{"AllianceGenome": "1421", "HGNC": "1421", "MIM": "613698", "_id": "788", "_version": 1, "accession": {"genomic": ["AC134028.10", "CH471055.1", "CP068275.2", "NC_000003.12", "NC_060927.1", "NG_008171.1", "Y17775.1", "Y17776.1", "Y17777.1", "Y17779.1"], "protein": ["AAH01689.1", "BAG35801.1", "BAG63207.1", "CAA71367.1", "CAB55356.1", "EAW64929.1", "NP_000378.1", "O43772.1"], "rna": ["AK301744.1", "AK312962.1", "BC001689.2", "BI913588.1", "BQ018220.1", "DC360427.1", "NM_000387.6", "Y10319.1"], "translation": [{"protein": "CAA71367.1", "rna": "Y10319.1"}, {"protein": "AAH01689.1", "rna": "BC001689.2"}, {"protein": "NP_000378.1", "rna": "NM_000387.6"}, {"protein": "BAG35801.1", "rna": "AK312962.1"}, {"protein": "BAG63207.1", "rna": "AK301744.1"}]}, "alias": ["CAC", "CACT"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2018-05-22T16:00:00.000Z", "disease_label": "carnitine-acylcarnitine translocase deficiency", "gcep": "Fatty Acid Oxidation Disorders Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0008918", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_95c9aece-49b5-496f-9547-f6d03dd69b4f-2018-05-22T160000.000Z", "sop": "SOP6"}}, "ec": "2.7.11.1", "ensembl": {"gene": "ENSG00000178537", "protein": ["ENSP00000326305", "ENSP00000388563", "ENSP00000388986"], "transcript": ["ENST00000319017", "ENST00000430379", "ENST00000440964", "ENST00000479050"], "translation": [{"protein": "ENSP00000326305", "rna": "ENST00000319017"}, {"protein": "ENSP00000388986", "rna": "ENST00000430379"}, {"protein": "ENSP00000388563", "rna": "ENST00000440964"}], "type_of_gene": "protein_coding"}, "entrezgene": "788", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 15.1819068495, "exp_mis": 102.090075304, "exp_syn": 44.5726625337, "lof_z": 0.808935687083438, "mis_z": 0.536858779118681, "mu_lof": 1.06086845571e-06, "mu_mis": 9.43311024178e-06, "mu_syn": 4.05635145233e-06, "n_lof": 12.0, "n_mis": 91.0, "n_syn": 37.0, "p_li": 2.04566835698354e-07, "p_null": 0.557581897103547, "p_rec": 0.442417898329617, "syn_z": 0.703175352962001}, "bp": 906, "cds_end": 48936227, "cds_start": 48895142, "n_exons": 9, "nonpsych": {"exp_lof": 13.5671572719, "exp_mis": 92.2274385358, "exp_syn": 40.1686301432, "lof_z": 0.417849772522419, "mis_z": 0.589674586338838, "mu_lof": 1.06086845571e-06, "mu_mis": 9.43311024178e-06, "mu_syn": 4.05635145233e-06, "n_lof": 12.0, "n_mis": 81.0, "n_syn": 31.0, "p_li": 7.2188358017039e-08, "p_null": 0.75064804937923, "p_rec": 0.249351878432412, "syn_z": 0.910803005488311}, "nontcga": {"exp_lof": 13.9504008516, "exp_mis": 93.9059219267, "exp_syn": 40.9899002589, "lof_z": 1.04334788340445, "mis_z": 0.663517451297662, "mu_lof": 1.06086845571e-06, "mu_mis": 9.43311024178e-06, "mu_syn": 4.05635145233e-06, "n_lof": 10.0, "n_mis": 81.0, "n_syn": 36.0, "p_li": 5.509209585408e-06, "p_null": 0.33005884736792, "p_rec": 0.669935643422495, "syn_z": 0.493486990188759}, "transcript": "ENST00000319017.4"}, "exons": [{"cdsend": 48898794, "cdsstart": 48857709, "chr": "3", "position": [[48856925, 48857772], [48858506, 48858631], [48859091, 48859201], [48859554, 48859627], [48862541, 48862659], [48879357, 48879448], [48883996, 48884124], [48891979, 48892072], [48898689, 48898882]], "strand": -1, "transcript": "NM_000387", "txend": 48898882, "txstart": 48856925}], "exons_hg19": [{"cdsend": 48936227, "cdsstart": 48895142, "chr": "3", "position": [[48894358, 48895205], [48895939, 48896064], [48896524, 48896634], [48896987, 48897060], [48899974, 48900092], [48916790, 48916881], [48921429, 48921557], [48929412, 48929505], [48936122, 48936315]], "strand": -1, "transcript": "NM_000387", "txend": 48936315, "txstart": 48894358}], "generif": [{"pubmed": 15057979, "text": "A deficiency in CACT was treated with a carnitine diet and administration of medium-chain triglycerides."}, {"pubmed": 15365988, "text": "The clinical, biochemical, & molecular features of 6 CACT-deficient patients from Italy, Spain, & North America who had significant clinical heterogeneity are reported. 5 novel & 3 previously reported mutations were found."}, {"pubmed": 15515015, "text": "The modulation of CACT expression has consequences for CPT 1 activity, while the biologic effects of acetyl-carnitine are not associated with a generic supply of energy compounds but to the anaplerotic property of the molecule."}, {"pubmed": 17508264, "text": "Report the outcome of two siblings with CACT deficiency."}, {"pubmed": 18307102, "text": "Functional analysis of mutations of residues Pro278 and Ala279 in A. nidulans, together with kinetic data in reconstituted liposomes, suggest a predominant structural role for these amino acids."}, {"pubmed": 19748481, "text": "PPARalpha regulates the expression of human SLC25A20 via the peroxisome proliferator responsive element."}, {"pubmed": 20877624, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21130740, "text": "These results show that FOXA and Sp1 sites in HepG2 cells and only the Sp1 site in HEK293 and SK-N-SH cells have a critical role in the transcriptional regulation of the CAC proximal promoter."}, {"pubmed": 22560224, "text": "Results show Steroid Receptor Coactivator-3 (SRC-3) plays a central role in long chain fatty acid metabolism by directly regulating carnitine/acyl-carnitine translocase (CACT) gene expression."}, {"pubmed": 23266187, "text": "Compares and contrasts all the known human SLC25A* genes and includes functional information."}, {"pubmed": 23322164, "text": "CPT2 and CACT are crucial for mitochondrial acylcarnitine formation and export to the extracellular fluids in mitochondrial fatty acid beta-oxidation disorders."}, {"pubmed": 24088670, "text": "C.576G>A, c.106-2a>t and c.516T>C are novel CACT gene mutations."}, {"pubmed": 25325845, "text": "The antiport mode of transport, typical of mitochondrial carriers such as CAC, results from coupling of uniport reactions in opposite directions mediated by specific amino acid residues."}, {"pubmed": 28671672, "text": "We provide evidence that the downregulation of hsa-miR-124-3p, hsa-miR-129-5p and hsa-miR-378 induced an increase in both expression and activity of CPT1A, CACT and CrAT in malignant prostate cells."}, {"pubmed": 29137068, "text": "we report the first 2 cases of CACTD identified from the mainland China. Apart from a founder mutation c.199-10T>G, we have identified a novel c.1A>G mutation. Patients with Carnitine-acylcarnitine translocase deficiency with a genotype of c.199-10T>G mutation usually presents with a severe clinical phenotype. Early recognition and appropriate treatment is crucial in this highly lethal disorder."}, {"pubmed": 34449152, "text": "Clinical and molecular characteristics of carnitineacylcarnitine translocase deficiency with c.270delC and a novel c.408C>A variant."}, {"pubmed": 34626609, "text": "Novel mutations associated with carnitine-acylcarnitine translocase and carnitine palmitoyl transferase 2 deficiencies in Malaysia."}, {"pubmed": 37371573, "text": "Inhibition of the Mitochondrial Carnitine/Acylcarnitine Carrier by Itaconate through Irreversible Binding to Cysteine 136: Possible Pathophysiological Implications."}, {"pubmed": 38565514, "text": "[Clinical and genetic analysis of two pedigrees affected with Carnitine-acylcarnitine translocase deficiency due to variant of SLC25A20 gene]."}], "genomic_pos": {"chr": "3", "end": 48898904, "ensemblgene": "ENSG00000178537", "start": 48856926, "strand": -1}, "genomic_pos_hg19": {"chr": "3", "end": 48936426, "start": 48894369, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001701", "qualifier": "involved_in", "term": "in utero embryonic development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006839", "qualifier": "involved_in", "term": "mitochondrial transport"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006853", "qualifier": "involved_in", "term": "carnitine shuttle"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:1902603", "qualifier": "involved_in", "term": "carnitine transmembrane transport"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1902603", "qualifier": "involved_in", "term": "carnitine transmembrane transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1902616", "qualifier": "involved_in", "term": "acyl carnitine transmembrane transport"}], "CC": [{"evidence": "HDA", "gocategory": "CC", "id": "GO:0005739", "pubmed": 20833797, "qualifier": "located_in", "term": "mitochondrion"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005739", "qualifier": "located_in", "term": "mitochondrion"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005740", "qualifier": "is_active_in", "term": "mitochondrial envelope"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005743", "qualifier": "located_in", "term": "mitochondrial inner membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 32814053, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "EXP", "id": "GO:0015227", "pubmed": 9399886, "qualifier": "enables", "term": "acyl carnitine transmembrane transporter activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0015227", "qualifier": "enables", "term": "acyl carnitine transmembrane transporter activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0015227", "qualifier": "enables", "term": "acyl carnitine transmembrane transporter activity"}]}, "homologene": {"genes": [[3702, 834724], [4530, 4349475], [4932, 854267], [5141, 3878256], [6239, 177530], [7165, 1276776], [7227, 33470], [7955, 393833], [8364, 394703], [9031, 416062], [9544, 709029], [9598, 460354], [9606, 788], [9615, 484774], [9913, 518758], [10090, 57279], [10116, 117035], [28985, 2892598], [33169, 4619967], [318829, 2682059]], "id": 331}, "interpro": [{"desc": "Mitochondrial substrate/solute carrier", "id": "IPR018108", "short_desc": "Mitochondrial_sb/sol_carrier"}, {"desc": "Mitochondrial carrier domain superfamily", "id": "IPR023395", "short_desc": "Mt_carrier_dom_sf"}], "ipi": ["IPI00013957", "IPI00926978", "IPI00927166", "IPI01010071"], "map_location": "3p21.31", "name": "solute carrier family 25 member 20", "other_names": ["mitochondrial carnitine/acylcarnitine carrier protein", "solute carrier family 25 (carnitine/acylcarnitine translocase), member 20"], "pantherdb": {"HGNC": "1421", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1928738", "ortholog_type": "LDO", "panther_family": "PTHR45624", "taxid": 10090, "uniprot_kb": "Q9Z2Z6"}, {"RGD": "621443", "ortholog_type": "LDO", "panther_family": "PTHR45624", "taxid": 10116, "uniprot_kb": "P97521"}, {"Ensembl": "ENSGALG00000028227", "ortholog_type": "LDO", "panther_family": "PTHR45624", "taxid": 9031, "uniprot_kb": "R4GLG2"}, {"ZFIN": "ZDB-GENE-040426-1869", "ortholog_type": "LDO", "panther_family": "PTHR45624", "taxid": 7955, "uniprot_kb": "Q6P5K6"}, {"WormBase": "WBGene00000996", "ortholog_type": "LDO", "panther_family": "PTHR45624", "taxid": 6239, "uniprot_kb": "Q27257"}, {"FlyBase": "FBgn0031881", "ortholog_type": "O", "panther_family": "PTHR45624", "taxid": 7227, "uniprot_kb": "Q9VM51"}, {"FlyBase": "FBgn0019830", "ortholog_type": "LDO", "panther_family": "PTHR45624", "taxid": 7227, "uniprot_kb": "Q9VQG4"}, {"SGD": "S000005626", "ortholog_type": "LDO", "panther_family": "PTHR45624", "taxid": 4932, "uniprot_kb": "Q12289"}], "uniprot_kb": "O43772"}, "pathway": {"kegg": {"id": "hsa04714", "name": "Thermogenesis - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-200425", "name": "Carnitine metabolism"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-8978868", "name": "Fatty acid metabolism"}], "smpdb": [{"id": "SMP00030", "name": "Oxidation of Branched Chain Fatty Acids"}, {"id": "SMP00052", "name": "Beta Oxidation of Very Long Chain Fatty Acids"}, {"id": "SMP00481", "name": "Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids"}, {"id": "SMP00482", "name": "Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids"}, {"id": "SMP00516", "name": "Adrenoleukodystrophy, X-linked"}, {"id": "SMP00517", "name": "Carnitine-acylcarnitine translocase deficiency"}], "wikipathways": [{"id": "WP143", "name": "Fatty acid beta-oxidation"}, {"id": "WP368", "name": "Mitochondrial LC-Fatty Acid Beta-Oxidation"}, {"id": "WP4321", "name": "Thermogenesis"}]}, "pfam": "PF00153", "pharmgkb": "PA35031", "pharos": {"target_id": 7202, "tdl": "Tbio"}, "prosite": "PS50920", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF246691", "relationship": "is"}, {"id": "GNF246692", "relationship": "is"}, {"id": "GNF246693", "relationship": "is"}, {"id": "GNF246694", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF161541", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF047319", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": {"id": "GNF090878", "relationship": "is"}, "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051928", "relationship": "is"}, {"id": "GNF056693", "relationship": "is"}, {"id": "GNF061486", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070001", "relationship": "is"}, {"id": "GNF070002", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF013494", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF104525", "relationship": "is"}, {"id": "GNF144173", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000003.12", "NC_060927.1", "NG_008171.1"], "protein": "NP_000378.1", "rna": "NM_000387.6", "translation": {"protein": "NP_000378.1", "rna": "NM_000387.6"}}, "reporter": {"HG-U133_Plus_2": "203658_at", "HG-U95Av2": "32376_at", "HTA-2_0": "TC03001390.hg.1", "HuEx-1_0": "2673773", "HuGene-1_1": "8087224", "HuGene-2_1": "16953753"}, "summary": "This gene product is one of several closely related mitochondrial-membrane carrier proteins that shuttle substrates between cytosol and the intramitochondrial matrix space. This protein mediates the transport of acylcarnitines into mitochondrial matrix for their oxidation by the mitochondrial fatty acid-oxidation pathway. Mutations in this gene are associated with carnitine-acylcarnitine translocase deficiency, which can cause a variety of pathological conditions such as hypoglycemia, cardiac arrest, hepatomegaly, hepatic dysfunction and muscle weakness, and is usually lethal in new born and infants. [provided by RefSeq, Jul 2008].", "symbol": "SLC25A20", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1413076"}, "unigene": "Hs.13845", "uniprot": {"Swiss-Prot": "O43772", "TrEMBL": ["F8WEF6", "C9JPE1"]}}